دورية أكاديمية
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors
| العنوان: | A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors |
|---|---|
| المؤلفون: | Campos, SusanaAff1, IDs10147022022470_cor1, Matulonis, Ursula, Berlin, Suzanne, Horowitz, Neil, Liu, Joyce, Krasner, Carolyn, Hang, Lee, Zarwan, Corrine, Barry, WilliamAff1, Aff9, Colella, Tina, Whalen, Christen, Shoni, Melina, Lundquist, Christine, Birrer, Michael J., Penson, Richard |
| المصدر: | International Journal of Clinical Oncology. 27(12):1881-1890 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 13419625 14377772 |
|---|---|
| DOI: | 10.1007/s10147-022-02247-0 |